Lack of efficacy of erlotinib in most EGFR mutated non-small cell lung cancers (NSCLCs) with acquired resistance to gefitinib

Abstract only

Saved in:

Bibliographic Details
Published in	Journal of clinical oncology Vol. 26; no. 15_suppl; p. 8105
Main Authors	Costa, D. B., Cho, B. C., Sequist, L. V., Riely, G. J., Halmos, B., Kim, J., Huberman, M. S., Pao, W., Tenen, D. G., Kobayashi, S.
Format	Journal Article
Language	English
Published	20.05.2008
Online Access	Get full text

Loading…